Navigation Links
Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
Date:7/10/2009

MORRISTOWN, N.J., July 10 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it has resumed shipments to reintroduce its intravenous iron replacement therapy INFeD (iron dextran injection,USP). The product, which had been out of stock due to changes in the final product manufacturing site and issues with raw material supply, is re-entering the market earlier than expected. Watson expects to be in a normal supply situation for INFeD shortly.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)

About INFeD(R)

INFeD(R) is an iron dextran injection indicated for the treatment of patients with documented iron deficiency anemia in whom oral administration is unsatisfactory or impossible. INFeD was approved, and has been available for clinical use in the U.S since 1992.

Important Safety Information

The parenteral use of complexes of iron and carbohydrates has resulted in anaphylactic-type reactions. Deaths associated with such administration have been reported. Therefore, INFeD should be used only in those patients in whom the indications have been clearly established and laboratory investigations confirm an iron-deficient state not amenable to oral iron therapy. Because fatal anaphylactic reactions have been reported after administration of iron dextran injection, the drug should be given only when resuscitation techniques and treatment of anaphylactic and anaphylactoid shock are readily available. Test dose is required.

INFeD should be used with caution in individuals with histories of significant allergies and/or asthma, and is contraindicated in patients with hypersensitivity to the
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Today the nonprofit Alliance ... through Vaccination in Older Adults, that provides a comprehensive overview of the factors ... and health care experts can improve patient compliance. , Although influenza, pneumococcal, tetanus, ...
(Date:7/29/2015)... ... ... Join Luz Delia Gerber and Abbi Ferrin as they share their empowering ... the body actually works. A state of mindfulness allows one to be present and ... to forge this new relationship with their bodies. , Abi Ferrin has a passion ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... with its Topricin® Pain Relief and Healing Cream designated as the nonprofit’s natural ... that is actively addressing Line of Duty Deaths (LODD) and the high rate ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami Herald ... alcohol addiction and mental health disorders. Acu-detox may begin taking off in the South ... drug and alcohol addiction. Although acupuncture is not a new practice, it is not ...
(Date:7/29/2015)... ... , ... For the second year in a row, the management and staff ... fastest growing companies in Jacksonville. This annual list is compiled by the Jacksonville Business ... of Vast Bridges staffers were on hand to receive the award naming the company ...
Breaking Medicine News(10 mins):Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Vast Bridges Continues Its Swift Growth 2
... March 29, 2011 If you want to increase your chances of ... new Kaiser Permanente study found that people trying to lose at ... they had lower stress levels and slept more than six hours ... published today in the International Journal of Obesity , was ...
... California, San Francisco and the University of California, Berkeley ... of airport security scanners is low based on the ... they are operated and function correctly. "The doses ... a professor of radiology at UCSF, who made the ...
... Reporter , MONDAY, March 28 (HealthDay News) -- Teens who ... a decline in bone mass, just as adults do, according ... the bone mineral content of the 61 obese teens studied ... Kaulfers, an assistant professor of pediatrics at the University of ...
... Reporter , MONDAY, March 28 (HealthDay News) -- The lives ... heartbeat called atrial fibrillation, which raises their risk for stroke. ... to arise as often as it does. ... be prevented by curbing common heart risk factors such as ...
... MONDAY, March 28 (HealthDay News) -- Seeing other people ... itch, researchers suggest. The team at Wake Forest ... as "contagious itch." "It is conceivable that the ... similar to the ones involved in contagious yawning, a ...
... A drug approved to treat certain types of cancer ... with scleroderma, according to results from an open-label Phase ... in a Phase III trial, the gold standard for ... could potentially be a weapon against the chronic connective ...
Cached Medicine News:Health News:Moderate sleep and less stress may help with weight loss 2Health News:Moderate sleep and less stress may help with weight loss 3Health News:Analysis suggests cancer risk of backscatter airport scanners is low 2Health News:Analysis suggests cancer risk of backscatter airport scanners is low 3Health News:Teens' Weight Loss Surgery May Weaken Bones 2Health News:Teens' Weight Loss Surgery May Weaken Bones 3Health News:Healthy Lifestyles Could Halve Cases of Dangerous Irregular Heartbeat 2Health News:Seeing Others Scratch Can Trigger Your Own Itch 2Health News:Cancer drug shows promise for treating scleroderma 2Health News:Cancer drug shows promise for treating scleroderma 3
(Date:7/29/2015)... and PITTSBURGH , July 29, ... announced that it received regulatory clearance from the European ... its proposed acquisition of Perrigo Company plc (NYSE: ... Robert J. Coury commented, "Today marks yet ... acquisition of Perrigo and serves as further affirmation of ...
(Date:7/29/2015)... 2015  Efforts to improve working capital efficiency are ... in North America and ... effective working capital management will ease the difficulties caused ... pharma companies expect to invest in optimizing working capital ... http://photos.prnewswire.com/prnh/20150724/241957LOGO Analysis from Frost & ...
(Date:7/29/2015)... NEW YORK and COPENHAGEN, ... Biologics, a global leader in clinical and commercial ... (River Vision), a private company focused on ophthalmology, ... agreement for the process transfer and cGMP production ... targeting insulin-like growth factor 1 that is in ...
Breaking Medicine Technology:Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 2CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 3
... 2012  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... 31, 2012. (Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ) ... quarter with the European regulatory filing of the subcutaneous ... Frost, Ph.D., President and Chief Executive Officer, Halozyme. "Despite ...
... 2012  Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX ), ... commercialization of medically important pharmaceutical products for the treatment ... will be held on Wednesday, May 9, 2012 at ... quarter ended March 31, 2012 and a business outlook ...
Cached Medicine Technology:Halozyme Reports First Quarter 2012 Financial Results 2Halozyme Reports First Quarter 2012 Financial Results 3Halozyme Reports First Quarter 2012 Financial Results 4Halozyme Reports First Quarter 2012 Financial Results 5Halozyme Reports First Quarter 2012 Financial Results 6
... X-ray Aprons are the result of a ... leaded x-ray aprons. Constructed with a wear ... back, the Lead Free aprons exhibit the ... apron. Each apron weighs approximately 50% less ...
... Easy Ambulatory 2 EEG is an extremely modular ... channels of data while your patient is in the ... 5 oz. and is worn in a lightweight pouch. ... the pouch. The storage medium used is a standard ...
... EEG system is a fully digital 32-channel system ... practice or hospital need. It can be set ... laptop computer for out-of-lab data collection, or it ... designed carts that will hold a high performance ...
... Options System is designed to enable ... the knee or hip to regain ... the potential for restoration of function. ... requirements of a rotating hinge and ...
Medicine Products: